Marcio H. Ribeiro

Coimbra, 3000548, Portugal

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

CSF Tau proteins reduce misdiagnosis of sporadic Creutzfeldt-Jakob disease suspected cases with inconclusive 14-3-3 result.

CSF Tau proteins reduce misdiagnosis of sporadic Creutzfeldt-Jakob disease suspected cases with inconclusive 14-3-3 result.

Journal: Journal of neurology
Published: April 28, 2016

Pseudohypoparathyroidism type I-b with neurological involvement is associated with a homozygous PTH1R mutation.

Pseudohypoparathyroidism type I-b with neurological involvement is associated with a homozygous PTH1R mutation.

Journal: Genes, brain, and behavior
Published: February 10, 2016

Sporadic Creutzfeldt-Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay.

Sporadic Creutzfeldt-Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay.

Journal: Neuroscience
Published: January 18, 2016

Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin.

Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin.

Journal: Neuropeptides
Published: September 17, 2015

Protective effects of 3-alkyl luteolin derivatives are mediated by Nrf2 transcriptional activity and decreased oxidative stress in Huntington's disease mouse striatal cells.

Protective effects of 3-alkyl luteolin derivatives are mediated by Nrf2 transcriptional activity and decreased oxidative stress in Huntington's disease mouse striatal cells.

Journal: Neurochemistry international
Published: June 30, 2015

Overexpression of BDNF and Full-Length TrkB Receptor Ameliorate Striatal Neural Survival in Huntington's Disease.

Overexpression of BDNF and Full-Length TrkB Receptor Ameliorate Striatal Neural Survival in Huntington's Disease.

Journal: Neuro-degenerative diseases
Published: August 05, 2014

Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease.

Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: May 17, 2014

Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblasts.

Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblasts.

Journal: Molecular neurobiology
Published: February 03, 2014

Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells.

Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells.

Journal: Free radical biology & medicine
Published: November 15, 2013

Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells--protective effect of cystamine and creatine.

Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells--protective effect of cystamine and creatine.

Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: September 07, 2013

IGF-1 intranasal administration rescues Huntington's disease phenotypes in YAC128 mice.

IGF-1 intranasal administration rescues Huntington's disease phenotypes in YAC128 mice.

Journal: Molecular neurobiology
Published: August 22, 2013

Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells.

Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells.

Journal: Free radical biology & medicine
Published: January 23, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026